Advertisement
Advertisement
U.S. markets open in 8 hours 15 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
109.95-1.12 (-1.01%)
At close: 04:03PM EST
110.00 +0.05 (+0.05%)
After hours: 07:54PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close111.07
Open110.65
Bid0.00 x 800
Ask0.00 x 900
Day's Range109.81 - 111.26
52 Week Range93.25 - 130.94
Volume4,860,837
Avg. Volume4,894,713
Market Cap191.706B
Beta (5Y Monthly)0.67
PE Ratio (TTM)28.12
EPS (TTM)3.91
Earnings DateApr 18, 2023 - Apr 24, 2023
Forward Dividend & Yield2.04 (1.86%)
Ex-Dividend DateJan 12, 2023
1y Target Est122.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-24% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ABT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Abbott Laboratories
    The Argus Min Vol Model PortfolioRapidly rising inflation 2022 knocked stocks into a bear market. While growth strategies suffered the most, value strategies also declined. Even bond prices were lower last year. Volatility, which has dropped from the highs of 2020, still has not returned to pre-COVID levels. Is it time for investors to cash in their chips? We note that investors exit the stock market at their own peril, as long-term returns from equities consistently have outpaced long-term returns from other asset classes, such as fixed income and cash. As well, those fixed-income returns are from eras when the 10-year Treasury bond yield was much higher than the current 3.5% level. So what's a potential equity strategy for investors amid all the uncertainty? Argus believes that Min Vol is an all-weather strategy that is timely in any investing climate.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • Motley Fool

    Is Abbott Laboratories a Good Dividend Stock to Buy Now?

    It's that time of year when Wall Street analysts start adjusting their predictions, and one dividend-paying stock, in particular, is getting a lot of positive attention. Abbott Laboratories (NYSE: ABT) reported fourth-quarter earnings on Thursday, Jan. 26. Since then, Sanford C. Bernstein, Raymond James, Stifel Nicolaus, and Barclays have all raised their price targets on the healthcare conglomerate.

  • Simply Wall St.

    Abbott Laboratories Full Year 2022 Earnings: EPS Beats Expectations

    Abbott Laboratories ( NYSE:ABT ) Full Year 2022 Results Key Financial Results Revenue: US$43.7b (up 1.3% from FY 2021...

  • Insider Monkey

    Abbott Laboratories (NYSE:ABT) Q4 2022 Earnings Call Transcript

    Abbott Laboratories (NYSE:ABT) Q4 2022 Earnings Call Transcript January 25, 2023 Operator: Good morning and thank you for standing by. Welcome to Abbott’s Fourth Quarter 2022 Earnings Conference Call. This call is being recorded by Abbott. With the exception of any participants’ questions asked during the question-and-answer session, the entire call, including the question-and-answer session, […]

Advertisement
Advertisement